Go Digit General Insurance Acquires Stake in Dr Reddy’s Laboratories for ₹30.06 Crore

Go Digit General Insurance has acquired a 0.32% stake in pharmaceutical major Dr Reddy’s Laboratories through a cash infusion of ₹30.06 crore. The insurance company disclosed the transaction in a stock exchange filing on Tuesday.

Insurance Companies Diversifying into Healthcare

Go Digit’s move to invest in a pharmaceutical company aligns with a broader trend of insurance firms expanding into healthcare.

Notably, PB Fintech, which operates Policybazaar, has launched PB Healthcare, a subsidiary focused on healthcare services.

Go Digit’s Financial Performance

Go Digit General Insurance provides a range of insurance products, including motor, travel, and health insurance. For the December 2024 quarter, the company posted a total revenue of ₹2,676 crore and a net profit of ₹118 crore.

Stock Performance

On February 27, 2025, Go Digit General Insuranceshare price traded 1.71% higher at ₹306.55 at 10:17 AM (IST). Go Digit General Insurance’s share price reached a 52-week high of ₹407.55 and a 52-week low of ₹276.80. As per BSE, the total traded volume for the stock stood at 9165 shares with a turnover of ₹28.04 lakhs.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.